Clear market notes built around the JSE, the rand, and what matters locally.

2026-09-28 21:17 • The Motley Fool Positive Axe Cap view: Selective

The article compares Arm Holdings and Marvell Technology as AI chip stocks. Arm dominates smartphone processors with 99%+ market share and is expanding into data centers, but trades at a steep 123.7x forward P/E valuation with SoftBank controlling 86.4% of shares. Marvell grows faster (37% revenue growth) and trades at cheaper multiples (58x forward P/E), but faces customer concentration risk with its top 10 customers representing 82% of revenue. The author recommends Marvell as the better buy for growth-focused investors despite higher execution risks.

Axe note: Marvell offers faster growth and cheaper valuation versus Arm’s dominance but at higher execution risks.

2026-09-28 21:05 • The Motley Fool Positive Axe Cap view: Selective

Lexicon Pharmaceuticals stock surged nearly 6% after analyst Steve Seedhouse from Cantor Fitzgerald initiated coverage with an 'overweight' rating and $8 price target (over 4x the current $1.90 price). Seedhouse highlighted the company's progress on sotagliflozin, an FDA-approved heart failure drug being developed for hypertrophic cardiomyopathy, which works through a different mechanism than competing treatments.

Axe note: Lexicon Pharmaceuticals’ 6% jump after new analyst coverage offers lessons but limited relevance for SA investors.

2026-09-28 20:32 • The Motley Fool Negative Axe Cap view: Selective

BlackLine stock fell over 5% on Monday following a downgrade by DA Davidson analyst Lucky Schreiner from neutral to underperform with a $23 price target. Schreiner cited concerns that advanced AI models could enable customers to build custom solutions, threatening legacy vendors like BlackLine, especially given its premium pricing. The analyst notes customers are increasingly opting to build their own solutions rather than purchase third-party products.

Axe note: BlackLine's downgrade highlights risks for premium software vendors as clients lean toward in-house AI solutions.